Business Context and Reporting Period
Company: ILLUMINA, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: February 21, 2013
Event: Completion of the acquisition of Verinata Health, Inc.
Key Financial Metrics
This filing reports on a specific corporate transaction rather than periodic operating results. Consequently, standard financial metrics such as revenue, profit, cash flow, margins, and debt levels are not disclosed in this document.
Transaction Consideration:
- Aggregate Consideration: $350 million (subject to closing and post-closing adjustments).
- Milestone Payments: Up to $100 million payable through 2015.
Material Changes
On February 21, 2013, Illumina, Inc. completed the merger of its wholly-owned subsidiary, TP Corporation, with and into Verinata Health, Inc. Verinata continues as a wholly-owned subsidiary of Illumina. This transaction represents a material change in the Company's asset base and corporate structure.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release on February 21, 2013, announcing the completion of the Merger. The filing incorporates the full text of the Merger Agreement (dated January 6, 2013) by reference.
Risks and Contingencies: The consideration paid is subject to certain closing and post-closing adjustments as defined in the Merger Agreement. Future cash outflows are contingent upon the achievement of milestones through 2015.
Investor Verification Checklist
- Verify the specific terms of the closing and post-closing adjustments affecting the $350 million consideration.
- Review the full Merger Agreement (Exhibit 2.1) for details on the $100 million milestone payment criteria.
- Confirm the integration status of Verinata Health, Inc. as a wholly-owned subsidiary.
- Check subsequent filings for the impact of this acquisition on consolidated financial statements.